C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor

Kidney International

Volumn 56, Issue 5, 1999, Pages 1729-1736

  Peake, Philip W ^a   O'Grady, Sue ^a   Pussell, Bruce A ^a   Charlesworth, John A ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

C3a receptor; Complement; HK 2 tubular cells; Kidney; Phosphorylation; Proximal tubule cells

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERSTITIAL NEPHRITIS; KIDNEY PROXIMAL TUBULE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0032723087     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00722.x     Document Type: Article

References (41)

1. JOHNSON DW, SAUNDERS HJ, BREW BK, GANESAN A, BAXTER RC, PORONNIK P, COOK DI, GYORY AZ, FIELD MJ, POLLOCK CA: Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. Kidney lut 52:1486-1496, 1997
2. GERRITSMA JS, DE GERRITSEN AF, LEV M, VAN Es LA, DAHA MR: Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokinc 9:276-283, 1997
3. HEALY E, BRADY HR: Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Citrr Opin Nephrol Hypertens 7:525-530, 1998
4. JOHNSON DW, SAUNDERS HJ, BAXTER RC, FIELD MJ, POLLOCK CA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54:747-757, 199S
5. PHILLIPS AO, STEADMAN R, TOPLEY N, WILLIAMS JD: Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet-derived growth factor. Am J Patliol 147:362-374, 1995
6. SCIILONDORFF D, NELSON PJ, LucKow B, SANAS B: Chemokines and renal disease. Kidney Int 51:610-621, 1997
7. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions, (editorial) J Am Soc Nephrol 5:1273-1287, 1994
8. GERRITSMA JS, GERRITSEN AF, VAN KOOTEN C, VAN Es LA, DAHA MR: Interleukin-1 alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Mol Immunol 33:847-854, 1996
9. DAVID S, BIANCONE L, CASERTA C, BUSSOLATI B, CAMBI V, CAMUSSI G: Alternative pathway complement activation induces proin-flammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 12:51-56, 1997
10. BIANCONE L, DAVID S, DELLA PIETRA V, MONTRUCCHIO G, CAMBI V, CAMUSSI G: Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 45:451-460, 1994
11. RYAN MJ, JOHNSON G, KIRK J, FUERSTENBERG SM, ZAGER RA, TOROK-STORB B: HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48-57, 1994
12. CIANFLONE K, MASLOWSKA M: Differentiation-induced production of ASP in human adipocytes. EUT J Clin Invest 25:817-325,1995
13. AVERY VM, ADRIAN DL, GORDON DL: Detection of mosaic protein mRNA in human astrocytes. Immunol Cell Biol 71:215-219,1993
14. NOLAN KF, SCHWAEBLE W, KALUZ S, DiERicii MP, REiD KB: Molecular cloning of the cDN A coding for properdin, a positive regulator of the alternative pathway of human complement. Eur J Immunol 21:771-776, 1991
15. GOLDBERGER G, BRUNS GA, RlTS M, EDGE MD, KWIATKOWSKI DJ: Human complement factor I: Analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4. J Biol Cliem 262:10065-10071, 1987
16. CRASS T, RAFFETSEDER U, MARTIN U, GROVE M, KLOS A, KOHL J, BAUTSCH W: Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur J Immunol 26:1944-1950, 1996
17. CARRE PC, MORTENSON RL, KING TE JR, NOBLE PW, SABLE CL, RICHES DW: Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary flbrosis: A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 88:1802-1810, 1991
18. SONG D, ZHOU W, SHEERIN SH, SACKS SH: Compartmental localization of complement component transcripts in the normal human kidney. Nephron 78:15-22, 1998
19. VAN DEN DOBBELSTEEN ME, VERIIASSELT V, KAASHOEK JG, TlMMERMAN JJ, SCHROEIJERS WE, VERWEIJ CL, VAN DER WoUDE FJ, VAN Es LA, DAHA MR: Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin Exp Immunol 95:173-180, 1994
20. TlMMERMAN JJ, BEERSMA MF, VAN GlJLSWIJK-jANSSEN DJ, VAN Es LA, VAN DER WOUDE FJ, DAHA MR: Differential effects of cytomegalovirus infection on complement synthesis by human mesangial cells. Clin Exp Immunol 109:518-525, 1997
21. PEAKE PW, O'GRADY S, PUSSELL BA, CIIARLESWORTH JA: Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest 27:922-927, 1997
22. CIANFLONE K: Acylation stimulating protein and the adipocyte. J Endocrinol 155:203-206, 1997
23. COUPES BM, KON SP, BRENCHLEY PE, SHORT CD, MALLICK NP: The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant 8:397-401, 1993
24. KON SP, COUPES B, SHORT CD, SOLOMON LR, RAFTERY MJ, MALLICK NP, BRENCHLEY PE: Urinary C5b-9 excretion and clinical course .. in idiopathic human membranous nephropathy. Kidney Int 48:1953-1958, 1995
25. MULLER TF, NEUMANN CM, GREB C, KRAUS M, LANGE H: The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection. Transplant Int 9:S58-S62, 1996
26. Hsu MH, EMBER JA, WANG M, PROSSNITZ ER, HUGLI TE, YE RD: Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics 47:64-72, 1997
27. LEGLER DF, LOETSCIIER M, JONES SA, DAHINDEN CA, AROCK M, MOSER B: Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur J Immunol 26:753-758, 1996
28. NILSSON G, JOIINELL M, HAMMER CH, TIFFANY HL, NILSSON K, METCALFE DD, SIEGBAIIN A, MURPHY PM: C3a and C5a are chemotoxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693-1698, 1996
29. AMES RS, Li Y, SARAU HM, NUTHULAGANTI P, FOLEY JJ, ELLIS C, ZENG Z, Su K, JUREWICZ AJ, HERTZBERG RP, BERGSMA DJ, KUMAR C: Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Cliem 271:20231-20234, 1996
30. GIANNINI E, BROUCHON L, BOULAY F: Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo. J Biol Cliem 270:19166-19172, 1995
31. RICHARD S, FARRELL CA, SHAW AS, SHOWELL HJ, CONNELLY PA: C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil. J Immunol 152:2479-2487, 1994
32. FUKUOKA Y, TACHIBANA T, YASUI A: Anaphylatoxin C3a induces rapid protein phosphorylation in guinea pig platelets, linmunopharmacology 28:95-104, 1994
33. COIIEN AH, NAST CC: TGF-beta in renal allograft rejection. Miner Electrolyte Metab 24:197-201, 1998
34. PARK IS, KIYOMOTO H, ABBOUD SL, ABBOUD HE: Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
35. SHARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146, 1995
36. BERTELLI R, VALENTI F, OLEGGINI R, CARIDI G, AUTIERI P, COVIELLO DA, BOTTI G, RAVAZZOLO R, GHIGGERI GM: Cell-specific regulation of alphal (III) and alpha2 (V) collagen by TGF-betal in tubulointerstitial cell models. Nephrol Dial Transplant 13:573-579, 1998
37. KAGAMI S, KUHARA T, YASUTOMO K, OKADA K, LOSTER K, REUTTER W, KURODA Y: Transforming growth factor-beta (TGF-beta) stimulates the expression of betal integrins and adhesion by rat mesangial cells. Exp Cell Res 229:1-6, 1996
38. ZWIRNER J, GöTZE O, SIEBER A, KAPP A, BEGEMANN G, ZUBERBIER T, WERFELî: The human mast cell line HMC-1 binds and responds to C3a but not C3a (desArg). Scaml J Immunol 47:19-24, 1998
39. DAFFERN PJ, PFEIFER PH, EMBER JA, HUGLI TE: C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181:2119-2127, 1995
40. TAKABAYASHI T, VANNIER E, CLARK BD, MARGOLIS NH, DINARELLO CA, BURKE JF, GELFAND JA: A new biologic role for C3a and C3a desArg: Regulation of TNF-alpha and IL-1 beta synthesis. J Immunol 156:3455-3460, 1996
41. FISCHER WH, HUGLI TE: Regulation of B cell functions by C3a and C3a (desArg): Suppression of TNF-alpha, IL-6, and the polyclonal immune response. J Immunol 159:4279-4286, 1997